Pebblebrook Hotel Trust
PEB- Exchange
- NYSE
- Industry
- Real Estate Investment Trusts
- SEC CIK
- 0001474098
No open-market purchases or sales by Pebblebrook Hotel Trust insiders were filed in the last 90 days; 295 institutions reported holding it in 13F filings for Q2 2026, worth $2.77B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 30, 2026, 1:18 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $65.8M (4.5% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 25, 2026 | Feb 26, 2025 | Feb 21, 2024 | Jan 20, 2023 | Feb 22, 2022 |
| Revenue | $1.48B | $1.45B | $1.42B | $1.39B | $733.0M |
| Selling, general and administrative | $49.5M | $48.1M | $44.8M | $39.2M | $38.2M |
| Operating income | $43.8M | $84.0M | $37.8M | $14.7M | -$89.8M |
| Interest expense | – | – | $115.7M | $100.0M | $96.6M |
| Income tax | $6.29M | -$25.6M | $655.0K | $277.0K | $61.0K |
| Net income | -$65.8M | -$4.24M | -$78.0M | -$87.2M | -$184.9M |
| EPS, basic | $-0.90 | $-0.39 | $-0.93 | $-0.95 | $-1.80 |
| EPS, diluted | $-0.90 | $-0.39 | $-0.93 | $-0.95 | $-1.80 |
| Weighted shares, basic | 117.0M | 119.8M | 121.8M | 130.5M | 130.8M |
| Weighted shares, diluted | 117.0M | 119.8M | 121.8M | 130.5M | 130.8M |
| Margins and growth | |||||
| Operating margin | 3.0% | 5.8% | 2.7% | 1.1% | -12.2% |
| Net margin | -4.5% | -0.3% | -5.5% | -6.3% | -25.2% |
| Revenue growth, year over year | +1.5% | +2.3% | +2.0% | +89.9% | +65.5% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 25, 2026 | Feb 26, 2025 | Feb 21, 2024 | Jan 20, 2023 | Feb 22, 2022 |
| Cash and equivalents | $184.2M | $206.7M | $183.7M | $41.0M | $58.5M |
| Total assets | $5.35B | $5.69B | $5.82B | $6.13B | $6.26B |
| Long-term debt | $2.12B | $2.25B | $2.32B | $2.39B | $2.44B |
| Total liabilities | $2.79B | $2.91B | $2.97B | $3.05B | $3.10B |
| Shareholders' equity | $2.56B | $2.79B | $2.85B | $3.08B | $3.16B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 25, 2026 | Feb 26, 2025 | Feb 21, 2024 | Jan 20, 2023 | Feb 22, 2022 |
| Operating cash flow | $249.7M | $275.0M | $236.2M | $278.7M | $70.8M |
| Capital expenditures | $97.4M | – | – | – | – |
| Free cash flow | $152.3M | – | – | – | – |
| Stock-based compensation | $13.7M | $13.6M | $12.5M | $11.3M | $11.4M |
| Dividends paid | $4.76M | $4.87M | $4.97M | $5.29M | $5.28M |
| Share buybacks | $72.6M | $16.9M | $92.8M | $70.7M | $720.0K |
| Investing cash flow | $10.3M | -$92.8M | $142.0M | -$109.4M | -$81.6M |
| Financing cash flow | -$281.4M | -$158.2M | -$236.8M | -$209.3M | -$33.3M |
| Net change in cash | -$21.4M | $23.9M | $141.4M | -$40.0M | -$44.1M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.9% | 0.9% | 0.9% | 0.8% | 1.6% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 23, 2026 | 111.7M | −1.7% | SEC |
| Jul 24, 2026 | 112.8M | −4.8% | SEC |
| Apr 24, 2026 | 113.4M | −4.5% | SEC |
| Feb 20, 2026 | 113.8M | −5.0% | SEC |
| Oct 31, 2025 | 113.6M | −5.1% | SEC |
| Jul 25, 2025 | 118.6M | −1.6% | SEC |
| Apr 25, 2025 | 118.7M | −1.5% | SEC |
| Feb 21, 2025 | 119.8M | −0.4% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.